Parker Institute for Cancer Immunotherapy
Other
Parker Institute accelerates development of breakthrough cancer immunotherapies through collaborative research network.
Early Stage
Biotech
Healthcare
- Headquarters
- San Francisco, United States
- Founded
- 2016
- Website
- parkerici.org
- Total Investments
- 6
- Last Investment
- Jul 2025
- Geographic Focus
- United States
Investment Thesis
Break barriers in cancer immunotherapy research to rapidly develop curative immune therapies.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account